Gene · 10410
Papers3,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study of Interferon-Induced Transmembrane Protein 3 Gene Polymorphism and Serum Interferon-λ3 Level in COVID-19. | Int J Immunogenet | 2026 | 41199463 | PubTator, text mining | PubMed |
| Selective Autophagy Mediated by Protein Ubiquitination in Major Prevalent Zoonoses. | Transbound Emerg Dis | 2025 | 41799925 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| Genistein Reduces the Risk of Diabetes in Long-Term Hospitalized Schizophrenic Patients. | Behav Sci (Basel) | 2025 | 41594962 | PubTator, text mining | PubMed |
| Study on the spatiotemporal regulation of interferon-stimulated genes during Zika virus infection. | Front Immunol | 2025 | 41573570 | PubTator, text mining | PubMed |
| Clinical characteristics of SARS-CoV-2 infection in patients with chronic hepatitis B during interferon antiviral therapy. | Biosaf Health | 2025 | 41541060 | PubTator, text mining | PubMed |
| IFITM3-expressing Lactobacillus plantarum (HA-r-LAB) as a probiotic vector for targeted immunotherapy against TGEV. | Vet Res | 2025 | 41462343 | PubTator, text mining | PubMed |
| Novel ubiquitination-related biomarkers for Crohn's disease identified by multi-omics study and experimental validation. | Front Immunol | 2025 | 41425573 | PubTator, text mining | PubMed |
| Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT. | Acta Neuropathol Commun | 2025 | 41408661 | PubTator, text mining | PubMed |
| Interferon-induced transmembrane proteins as biomarkers for assessing the diagnosis and severity of coronary artery disease and acute myocardial infarction. | Front Med (Lausanne) | 2025 | 41368318 | PubTator, text mining | PubMed |
| LncRNA CKMT2-AS1 Promotes Hepatocellular Carcinoma Development Via Sponging miR-142-5p and Targeting IFITM3. | Turk J Gastroenterol | 2025 | 41236096 | PubTator, text mining | PubMed |
| MARCH8-mediated ubiquitination regulates expression of the antiviral protein IFITM3. | J Biol Chem | 2025 | 41197719 | PubTator, text mining | PubMed |
| Combined effects of restriction factors and transduction adjuvants on lentiviral vector gene transfer efficacy. | Sci Rep | 2025 | 41188322 | PubTator, text mining | PubMed |
| Harnessing the power of exosomes in leukemia: from molecular messengers to clinical applications. | Discov Oncol | 2025 | 41171532 | PubTator, text mining | PubMed |
| IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer. | Mol Cancer | 2025 | 41152910 | PubTator, text mining | PubMed |
| Association of IFNL4 and IFITM3 Genetic Variants with Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma. | Asian Pac J Cancer Prev | 2025 | 41148623 | PubTator, text mining | PubMed |
| Progressively altered genes in colorectal carcinogenesis link oncogenesis immune cycle and tumor microenvironment. | Sci Rep | 2025 | 41145546 | PubTator, text mining | PubMed |
| Impact of IFITM3 rs12252 and IFNAR2 rs2236757 SNP polymorphisms on influenza virus infection outcomes in Moroccan patients. | Mol Biol Rep | 2025 | 41128776 | PubTator, text mining | PubMed |
| Exosomal biomarkers in leukemia: translational potential and regulatory challenges for precision medicine applications. | Front Immunol | 2025 | 41103412 | PubTator, text mining | PubMed |
| The dissipation theory of aging: a quantitative analysis using a cellular aging map. | NPJ Aging | 2025 | 41068147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10410/papers?page=5